JP2022530050A5 - - Google Patents
Info
- Publication number
- JP2022530050A5 JP2022530050A5 JP2021562990A JP2021562990A JP2022530050A5 JP 2022530050 A5 JP2022530050 A5 JP 2022530050A5 JP 2021562990 A JP2021562990 A JP 2021562990A JP 2021562990 A JP2021562990 A JP 2021562990A JP 2022530050 A5 JP2022530050 A5 JP 2022530050A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025036010A JP2025087851A (ja) | 2019-04-23 | 2025-03-07 | 安定な低粘度抗体製剤およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837518P | 2019-04-23 | 2019-04-23 | |
| US62/837,518 | 2019-04-23 | ||
| EP20305145 | 2020-02-17 | ||
| EP20305145.3 | 2020-02-17 | ||
| PCT/EP2020/061340 WO2020216847A1 (en) | 2019-04-23 | 2020-04-23 | Stable, low-viscosity antibody formulations and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025036010A Division JP2025087851A (ja) | 2019-04-23 | 2025-03-07 | 安定な低粘度抗体製剤およびその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022530050A JP2022530050A (ja) | 2022-06-27 |
| JP2022530050A5 true JP2022530050A5 (https=) | 2023-05-01 |
| JPWO2020216847A5 JPWO2020216847A5 (https=) | 2023-05-01 |
| JP7671697B2 JP7671697B2 (ja) | 2025-05-02 |
Family
ID=70295163
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562990A Active JP7671697B2 (ja) | 2019-04-23 | 2020-04-23 | 安定な低粘度抗体製剤およびその使用 |
| JP2025036010A Pending JP2025087851A (ja) | 2019-04-23 | 2025-03-07 | 安定な低粘度抗体製剤およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025036010A Pending JP2025087851A (ja) | 2019-04-23 | 2025-03-07 | 安定な低粘度抗体製剤およびその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220218607A1 (https=) |
| EP (1) | EP3958896A1 (https=) |
| JP (2) | JP7671697B2 (https=) |
| KR (1) | KR20220004104A (https=) |
| CN (1) | CN114286690A (https=) |
| AU (1) | AU2020262231A1 (https=) |
| BR (1) | BR112021021099A2 (https=) |
| CA (1) | CA3137464A1 (https=) |
| CO (1) | CO2021015561A2 (https=) |
| IL (1) | IL287435A (https=) |
| MA (1) | MA55750A (https=) |
| MX (1) | MX2021012968A (https=) |
| SG (1) | SG11202111740PA (https=) |
| TW (1) | TW202108171A (https=) |
| WO (1) | WO2020216847A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11655302B2 (en) | 2019-06-10 | 2023-05-23 | Sanofi | Anti-CD38 antibodies and formulations |
| MX2022006882A (es) * | 2019-12-05 | 2022-11-08 | Sanofi Aventis Us Llc | Formulaciones de anticuerpos anti-cd38 para administracion subcutanea. |
| WO2023109928A1 (zh) * | 2021-12-16 | 2023-06-22 | 上海宝济药业有限公司 | 抗免疫球蛋白降解酶酶切的Fc变体 |
| WO2024023843A1 (en) * | 2022-07-26 | 2024-02-01 | Dr. Reddy’S Laboratories Limited | A pharmaceutical formulation of a therapeuticantibody and preparations thereof |
| WO2026006689A2 (en) | 2024-06-28 | 2026-01-02 | Firefly Bio, Inc. | Bcl-xl degrader antibody conjugates and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5460944A (en) * | 1991-10-28 | 1995-10-24 | Boehringer Mannheim Gmbh | Storable protein solution |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| JP5577098B2 (ja) * | 2006-12-21 | 2014-08-20 | アムジエン・インコーポレーテツド | ポリペプチドを含有する安定な緩衝化された製剤 |
| WO2009120684A1 (en) * | 2008-03-25 | 2009-10-01 | Medimmune, Llc | Antibody formulation |
| NZ603698A (en) | 2008-07-08 | 2014-03-28 | Abbvie Inc | Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| KR20120060877A (ko) | 2009-09-01 | 2012-06-12 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
| AU2010306677B2 (en) | 2009-10-15 | 2013-05-23 | Abbvie Inc. | Dual variable domain immunoglobulins and uses thereof |
| UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| AR080428A1 (es) * | 2010-01-20 | 2012-04-11 | Chugai Pharmaceutical Co Ltd | Formulaciones liquidas estabilizadas contentivas de anticuerpos |
| BR112012021576A2 (pt) * | 2010-02-26 | 2016-10-25 | Novo Nordisk As | composições estáveis contendo anticorpo. |
| US9956165B2 (en) * | 2010-03-01 | 2018-05-01 | Cytodyn Inc. | Concentrated protein formulations and uses thereof |
| US8735546B2 (en) | 2010-08-03 | 2014-05-27 | Abbvie Inc. | Dual variable domain immunoglobulins and uses thereof |
| CA2864539C (en) * | 2012-02-16 | 2022-06-07 | Santarus, Inc. | Antibody formulations |
| HUE033369T2 (en) * | 2012-11-20 | 2017-11-28 | Sanofi Sa | Anti-ceacam5 antibodies and uses thereof |
| US20160058863A1 (en) * | 2014-09-03 | 2016-03-03 | Board Of Regents, The University Of Texas System | Low viscosity concentrated protein dispersions |
| WO2018119142A1 (en) * | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| KR20190095943A (ko) * | 2016-12-22 | 2019-08-16 | 사노피 | 고갈 활성을 갖는 인간화 cxcr3 항체 및 이의 사용 방법 |
-
2020
- 2020-04-23 BR BR112021021099A patent/BR112021021099A2/pt unknown
- 2020-04-23 US US17/604,890 patent/US20220218607A1/en active Pending
- 2020-04-23 EP EP20720057.7A patent/EP3958896A1/en active Pending
- 2020-04-23 SG SG11202111740PA patent/SG11202111740PA/en unknown
- 2020-04-23 AU AU2020262231A patent/AU2020262231A1/en active Pending
- 2020-04-23 MX MX2021012968A patent/MX2021012968A/es unknown
- 2020-04-23 WO PCT/EP2020/061340 patent/WO2020216847A1/en not_active Ceased
- 2020-04-23 CA CA3137464A patent/CA3137464A1/en active Pending
- 2020-04-23 JP JP2021562990A patent/JP7671697B2/ja active Active
- 2020-04-23 KR KR1020217037779A patent/KR20220004104A/ko not_active Ceased
- 2020-04-23 CN CN202080044419.0A patent/CN114286690A/zh active Pending
- 2020-04-23 TW TW109113601A patent/TW202108171A/zh unknown
- 2020-04-23 MA MA055750A patent/MA55750A/fr unknown
-
2021
- 2021-10-20 IL IL287435A patent/IL287435A/en unknown
- 2021-11-19 CO CONC2021/0015561A patent/CO2021015561A2/es unknown
-
2025
- 2025-03-07 JP JP2025036010A patent/JP2025087851A/ja active Pending